Peer-reviewedCC BYCureus
Tocilizumab in Acute Coronary Syndromes: A Systematic Review of Randomized Controlled Trials
- 1Cardiology, Mid Yorkshire Hospitals NHS Trust, Wakefield, GBR
- 2Medicine, King Edward Medical University, Lahore, PAK
Related
- Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes
- Escitalopram for psychological symptoms and cardiovascular outcomes in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials.
- Equity-Related Factors in Emergency Medical Service Use for Acute Coronary Syndromes: A Systematic Review.
- Effectiveness of Nursing Interventions on Stress and Functional Capacity Among Patients After Coronary Artery Bypass Grafting (CABG): A Randomized Controlled Trial
- Point-of-Care Ultrasound of Upper Airway Changes During Cardiopulmonary Bypass in Coronary Artery Bypass Grafting: A Randomized Controlled Trial
BibTeX
@article{iqbal2026tocilizumab,
title = {{Tocilizumab in Acute Coronary Syndromes: A Systematic Review of Randomized Controlled Trials}},
author = {Muhammad Umair Iqbal and Hassan Askari and Ira Abid and Bisma Hussain and Muhammad Hanan Abid and Aeyza Nasir},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13675067},
note = {CC BY},
}
RIS
TY - JOUR
TI - Tocilizumab in Acute Coronary Syndromes: A Systematic Review of Randomized Controlled Trials
AU - Muhammad Umair Iqbal
AU - Hassan Askari
AU - Ira Abid
AU - Bisma Hussain
AU - Muhammad Hanan Abid
AU - Aeyza Nasir
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13675067
SN - 2168-8184
ER -